Aβ42-positive non-pyramidal neurons around amyloid plaques in Alzheimer's disease
Abstract
Immunohistochemistry with end-specific antibodies against C-termini of Abeta40 and Abeta42 in Alzheimer's disease showed that Abeta42 immunoreactivity was localised intracellularly in subpopulations of neurons of patients with Alzheimer's disease.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Early increases in intracellular amyloid-β levels have been observed in vulnerable neurons of Alzheimer's disease human patients and animal models, preceding the appearance of amyloid-β plaques.
“Apart from extracellular deposition, early increases in intracellular Aβ levels have been observed in vulnerable neurons of AD human patients [41, 78] and animal models [22, 87, 110], preceding the appearance of Aβ plaques.”
From Senescence-related impairment of autophagy induces toxic intraneuronal amyloid-β accumulation in a mouse model of amyloid pathology (2023) · cites this paper as [78]
Intraneuronal amyloid-β accumulation in specific Alzheimer's disease-vulnerable neurons precedes the formation of extracellular amyloid-β plaques both in Alzheimer's disease patients and mouse models.
“Additionally, it has been shown that intraneuronal Aβ accumulation in specific AD-vulnerable neurons precedes the formation of extracellular Aβ plaques both in AD patients [41, 78] and mouse models [22, 87, 110].”
From Senescence-related impairment of autophagy induces toxic intraneuronal amyloid-β accumulation in a mouse model of amyloid pathology (2023) · cites this paper as [78]
Intraneuronal Aβ accumulation has been found in the brains of patients presenting AD or mild cognitive impairment and is suggested to represent an early step in AD neuropathology.
“Intraneuronal Aβ accumulation has been found in the brains of patients presenting AD or mild cognitive impairment [3, 21, 41, 47, 78], and studies suggest that this phenomenon represents an early step in AD neuropathology [40].”
From Senescence-related impairment of autophagy induces toxic intraneuronal amyloid-β accumulation in a mouse model of amyloid pathology (2023) · cites this paper as [78]
Two publications appeared in January 2000 on the intraneuronal accumulation of particularly Aβ42 by light microscopy within neurons of human brain.
“Two publications appeared in January 2000 on the intraneuronal accumulation of particularly Aβ42 by light microscopy within neurons of human brain.”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [123]
Cites
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · see citing works
Jarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022 · see citing works
Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., & Ihara, Y. (1994) · Neuron · doi:10.1016/0896-6273(94)90458-8 · Cited by 1,774 · see citing works
Cook, D. G., Forman, M. S., Sung, J. C., Leight, S., Kolson, D. L., Iwatsubo, T., Lee, V. M.-Y., & Doms, R. W. (1997) · Nature Medicine · doi:10.1038/nm0997-1021 · Cited by 439 · see citing works
Chui, D.-H., Tanahashi, H., Ozawa, K., Ikeda, S., Checler, F., Ueda, O., Suzuki, H., Araki, W., Inoue, H., Shirotani, K., et al. (1999) · Nature Medicine · doi:10.1038/8438 · Cited by 364 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Intracellular amyloid-β in Alzheimer's disease
LaFerla, F. M., Green, K. N., & Oddo, S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2168 · Cited by 1,942 · see citing works
Billings, L. M., Oddo, S., Green, K. N., McGaugh, J. L., & LaFerla, F. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.040 · Cited by 1,294 · see citing works
Cognitive Dysfunction and Diabetes Mellitus
Kodl, C. T., & Seaquist, E. R. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0034 · Cited by 823 · see citing works
Takahashi, R. H., Milner, T. A., Li, F., Nam, E. E., Edgar, M. A., Yamaguchi, H., Beal, M. F., Xu, H., Greengard, P., & Gouras, G. K. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64463-x · Cited by 706 · see citing works
Gasparini, L., Gouras, G. K., Wang, R., Gross, R. S., Beal, M. F., Greengard, P., & Xu, H. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02561.2001 · Cited by 492 · see citing works
Alpha 1 -Antitrypsin Deficiency — A Model for Conformational Diseases
Carrell, R. W., & Lomas, D. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmra010772 · Cited by 447 · see citing works
Protein‐misfolding diseases and chaperone‐based therapeutic approaches
Chaudhuri, T. K., & Paul, S. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05181.x · Cited by 423 · see citing works
Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease
Gouras, G. K., Tampellini, D., Takahashi, R. H., & Capetillo-Zarate, E. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0679-9 · Cited by 372 · see citing works
Wirths, O., Multhaup, G., & Bayer, T. A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02737.x · Cited by 349 · see citing works
Does insulin dysfunction play a role in Alzheimer's disease?
Gasparini, L. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02037-0 · Cited by 314 · see citing works
Intraneuronal Aβ42 accumulation in Down syndrome brain: Original Articles
Mori, C., Spooner, E. T., Wisniewski, K. E., Wisniewski, T. M., Yamaguchi, H., Saido, T. C., Tolan, D. R., Selkoe, D. J., & Lemere, C. A. (2002) · Amyloid · doi:10.3109/13506120208995241 · Cited by 255 · see citing works
Bayer (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00008 · Cited by 252 · see citing works
Extracellular protein components of amyloid plaques and their roles in Alzheimer’s disease pathology
Rahman, M. M., & Lendel, C. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00465-0 · Cited by 245 · see citing works
Magrané, J., Smith, R. C., Walsh, K. X., & Querfurth, H. W. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4330-03.2004 · Cited by 240 · see citing works
Giménez‐Llort, L., Blázquez, G., Cañete, T., Johansson, B. A., Oddo, S., Tobeña, A., LaFerla, F. M., & Fernández‐Teruel, A. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.07.007 · Cited by 232 · see citing works
Dual roles for autophagy: Degradation and secretion of Alzheimer's disease Aβ peptide
Nilsson, P., & Saido, T. C. (2014) · BioEssays · doi:10.1002/bies.201400002 · Cited by 202 · see citing works
Kienlen-Campard, P., Miolet, S., Tasiaux, B., & Octave, J.-N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200887200 · Cited by 187 · see citing works
Codeposition of Cystatin C with Amyloid-β Protein in the Brain of Alzheimer Disease Patients
Levy, E., Sastre, M., Kumar, A. R., Gallo, G., Piccardo, P., Ghetti, B. F., & Tagliavini, F. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.1.94 · Cited by 172 · see citing works
JNK activation is associated with intracellular β-amyloid accumulation
Shoji, M., Iwakami, N., Takeuchi, S., Waragai, M., Suzuki, M., Kanazawa, I., Lippa, C. F., Ono, S., & Okazawa, H. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00245-x · Cited by 166 · see citing works
Intraneuronal Aβ detection in 5xFAD mice by a new Aβ-specific antibody
Youmans, K. L., Tai, L. M., Kanekiyo, T., Stine Jr, W. B., Michon, S.-C., Nwabuisi-Heath, E., Manelli, A. M., Fu, Y., Riordan, S., Eimer, W. A., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-8 · Cited by 164 · see citing works
Chronic Intermittent Hypoxia/Reoxygenation Facilitate Amyloid-β Generation in Mice
Shiota, S., Takekawa, H., Matsumoto, S., Takeda, K., Nurwidya, F., Yoshioka, Y., Takahashi, F., Hattori, N., Tabira, T., Mochizuki, H., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130419 · Cited by 155 · see citing works
From Alzheimer to Huntington: why is a structural understanding so difficult?
Temussi, P. A., Masino, L., & Pastore, A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg044 · Cited by 147 · see citing works
Chu, S., Gu, J., Feng, L., Liu, J., Zhang, M., Jia, X., Liu, M., & Yao, D. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.01.018 · Cited by 137 · see citing works
LRP in Amyloid‐β Production and Metabolism
Bu, G., Cam, J. A., & Zerbinatti, C. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1377.005 · Cited by 133 · see citing works
Zerbinatti, C. V., Wahrle, S. E., Kim, H., Cam, J. A., Bales, K., Paul, S. M., Holtzman, D. M., & Bu, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604436200 · Cited by 129 · see citing works
Lafaye, P. J., Achour, I., England, P., Duyckaerts, C. J., & Rougeon, F. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.09.008 · Cited by 121 · see citing works
Morishima-Kawashima, M., Oshima, N., Ogata, H., Yamaguchi, H., Yoshimura, M., Sugihara, S., & Ihara, Y. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64847-x · Cited by 119 · see citing works
Accumulation of intraneuronal Aβ correlates with ApoE4 genotype
Christensen, D. Z., Schneider-Axmann, T., Lucassen, P. J., Bayer, T. A., & Wirths, O. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0666-1 · Cited by 120 · see citing works
Insights into Alzheimer disease pathogenesis from studies in transgenic animal models
Schaeffer, E. L., Figueiró, M., & Gattaz, W. F. (2011) · Clinics · doi:10.1590/s1807-59322011001300006 · Cited by 114 · see citing works
Iulita, M. F., Allard, S. T. M., Richter, L., Munter, L. M., Ducatenzeiler, A., Weise, C., Carmo, S. D., Klein, W. L., Multhaup, G., & Cuello, A. C. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-61 · Cited by 102 · see citing works
The JNK/c-Jun cascade and Alzheimer's disease
Okazawa, H., & Estus, S. (2002) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750201700209 · Cited by 97 · see citing works
Węgiel, J., Kuchna, I., Nowicki, K., Frackowiak, J., Mazur‐Kolecka, B., Imaki, H., Wegiel, J., Mehta, P. D., Silverman, W. P., Reisberg, ., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-006-0191-4 · Cited by 89 · see citing works
Intraneuronal Aβ accumulation and neurodegeneration: Lessons from transgenic models
Wirths, O., & Bayer, T. A. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.02.001 · Cited by 91 · see citing works
Yamaguchi, H., Maat–Schieman, M. L. C., van Duinen, S. G., Prins, F. A., Neeskens, P., Natté, R., & Roos, R. A. C. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.8.723 · Cited by 91 · see citing works
Mechanism of Neuronal versus Endothelial Cell Uptake of Alzheimer's Disease Amyloid β Protein
Kandimalla, K. K., Scott, O. G., Fulzele, S., Davidson, M. W., & Poduslo, J. F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004627 · Cited by 88 · see citing works
Early intraneuronal Aβ deposition in the hippocampus of APP transgenic mice
Shie, F., LeBoeur, R. C., & Jin, L. (2003) · Neuroreport · doi:10.1097/00001756-200301200-00023 · Cited by 83 · see citing works
Evidence of intraneuronal Aβ accumulation preceding tau pathology in the entorhinal cortex
Welikovitch, L. A., Carmo, S. D., Maglóczky, Z., Szocsics, P., Lőke, J., Freund, T. F., & Cuello, A. C. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1922-z · Cited by 80 · see citing works
Lee, E. B., Skovronsky, D., Abtahian, F., Doms, R. W., & Lee, V. M. ‐. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210105200 · Cited by 78 · see citing works
Ultrastructural Localization of Intraneuronal Aβ-Peptide in Alzheimer Disease Brains
Gómez-Ramos, P., & Asunción Morán, M. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-11109 · Cited by 76 · see citing works
Intracellular A-Beta Amyloid, A Sign for Worse Things to Come?
Echeverrı́a, V., & Cuello, A. C. (2002) · Molecular Neurobiology · doi:10.1385/mn:26:2-3:299 · Cited by 75 · see citing works
Iijima‐Ando, K., Hearn, S., Granger, L., Shenton, C., Gatt, A., Chiang, H., Hakker, I., Zhong, Y., & Iijima, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710509200 · Cited by 73 · see citing works
Apoptotic neurons in Alzheimer's disease frequently show intracellular Aβ42 labeling
Chui, D., Dobó, E., Makifuchi, T., Akiyama, H., Kawakatsu, S., Petit-Paitel, A., Checler, F., Araki, W., Takahashi, K., & Tabira, T. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3208 · Cited by 74 · see citing works
Sudoh, S., Frosch, M. P., & Wolf, B. A. (2002) · Biochemistry · doi:10.1021/bi011193l · Cited by 73 · see citing works
Aho, L., Pikkarainen, M., Hiltunen, M., Leinonen, V., & Alafuzoff, I. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091681 · Cited by 71 · see citing works
Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice
Rodrigo, J., Fernández‐Vizarra, P., Castro‐Blanco, S., Bentura, M. L., Nieto, M., Gómez‐Isla, T., Martínez‐Murillo, R., Martı́nez, A., Serrano, J., & Fernández, A. P. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.06.030 · Cited by 70 · see citing works
Alzheimer's disease-associated amyloid beta interacts with the human serine protease HtrA2/Omi
Park, H., Seong, Y.-M., Choi, J.-Y., Kang, S., & Rhim, H. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.11.068 · Cited by 67 · see citing works
Intracellular Trafficking Mechanisms of Synaptic Dysfunction in Alzheimer’s Disease
Perdigão, C., Barata, M. A., Araújo, M. N., Mirfakhar, F., Castanheira, J., & Almeida, C. G. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00072 · Cited by 56 · see citing works
Węgiel, J., Frackowiak, J., Mazur‐Kolecka, B., Schanen, N. C., Cook, E. H., Sigman, M., Brown, W. T., Kuchna, I., Wegiel, J., Nowicki, K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035414 · Cited by 64 · see citing works
Endocytic pathways mediating oligomeric Aβ42 neurotoxicity
Yu, C., Nwabuisi‐Heath, E., Laxton, K., & LaDu, M. J. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-19 · Cited by 61 · see citing works
Zerbinatti, C., & Bu, G. (2005) · Reviews in the Neurosciences · doi:10.1515/revneuro.2005.16.2.123 · Cited by 62 · see citing works
Iijima, K., & Iijima‐Ando, K. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15402 · Cited by 59 · see citing works
Thellung, S., Beatrice, S., Corsaro, A., Villa, V., Nizzari, M., Gagliani, M. C., Porcile, C., Russo, C., Pagano, A., Tacchetti, C., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0252-8 · Cited by 57 · see citing works
Christensen, D. Z., Bayer, T. A., & Wirths, O. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.014 · Cited by 47 · see citing works
Increased Aβ Production Leads to Intracellular Accumulation of Aβ in Flotillin-1-Positive Endosomes
Rajendran, L., Knobloch, M., Geiger, K. D., Dienel, S., Nitsch, R. M., Simons, K., & Konietzko, U. (2007) · Neurodegenerative Diseases · doi:10.1159/000101841 · Cited by 49 · see citing works
Suelves, N., Saleki, S., Ibrahim, T., Palomares, D., Moonen, S., Koper, M. J., Vrancx, C., Vadukul, D. M., Papadopoulos, N., Viceconte, N., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01578-x · Cited by 43 · see citing works
Independent Effects of Intra- and Extracellular Aβ on Learning-Related Gene Expression
Wegenast‐Braun, B. M., Maisch, A. F., Eicke, D., Radde, R., Herzig, M. C., Staufenbiel, M., Jucker, M., & Calhoun, M. E. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090044 · Cited by 40 · see citing works
γ-Secretase Cleavage Site Specificity Differs for Intracellular and Secretory Amyloid β
Grimm, H. S., Beher, D., Lichtenthaler, S. F., Shearman, M. S., Beyreuther, K. T., & Hartmann, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210380200 · Cited by 39 · see citing works
Association of ApoE and LRP mRNA levels with dementia and AD neuropathology
Akram, A. M., Schmeidler, J., Katsel, P., Hof, P. R., & Haroutunian, V. H. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.04.010 · Cited by 37 · see citing works
Novel approaches for immunotherapeutic intervention in Alzheimer's disease
Vasilevko, V., & Cribbs, D. H. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.03.019 · Cited by 37 · see citing works
Pathogenic role of mitochondrial amyloid-β peptide
Chen, J. X., & Yan, S. D. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.11.1517 · Cited by 26 · see citing works
HSV-1 cellular model reveals links between aggresome formation and early step of Alzheimer’s disease
Albaret, M. A., Textoris, J., Dalzon, B., Lambert, J., Linard, M., Helmer, C., Hacot, S., Ghayad, S. E., Ferréol, M., Mertani, H. C., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02376-8 · Cited by 25 · see citing works
Poduslo, J. F., Gilles, E. J., Ramakrishnan, M., Howell, K. G., Wengenack, T. M., Curran, G. L., & Kandimalla, K. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008813 · Cited by 23 · see citing works
Alzheimer's disease: Its diagnosis and pathogenesis
Kril, J. J., & Halliday, G. M. (2001) · International review of neurobiology · doi:10.1016/s0074-7742(01)48016-0 · Cited by 22 · see citing works
Pontrello, C. G., McWhirt, J., Glabe, C. G., & Brewer, G. J. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220824 · Cited by 20 · see citing works
Park, H., Kim, S.-S., Kang, S., & Rhim, H. (2009) · Brain Research · doi:10.1016/j.brainres.2009.04.001 · Cited by 19 · see citing works
López‐Noguerola, J. S., Gießen, N. M.-E., Ueberück, M., Meißner, J. N., Pelgrim, C. E., Adams, J., Wirths, O., Bouter, Y., & Bayer, T. A. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00064 · Cited by 18 · see citing works
Monsalvo-Maraver, L. Á., Maya-López, M., Rangel‐López, E., Túnez, I., Tinkov, A. A., Skalny, A. V., Ferrer, B., Aschner, M., & Santamarı́a, A. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220616094036 · Cited by 13 · see citing works
Kern, W., Jan Born, A., & Fehm, H. L. (2002) · Drug Development Research · doi:10.1002/ddr.10101 · Cited by 13 · see citing works
Type-specific evolution of amyloid plaque and angiopathy in APPsw mice
Harigaya, Y., Tomidokoro, Y., Ikeda, M., Sasaki, A., Kawarabayashi, T., Matsubara, E., Kanai, M., Saido, T. C., Younkin, S. G., & Shoji, M. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.10.087 · Cited by 13 · see citing works
Johansson, B. A., Oasa, S., Muntsant-Soria, A., Tiiman, A., Söderberg, L., Amandius, E., Möller, C., Lannfelt, L., Terenius, L. Y., Giménez‐Llort, L., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01086-4 · Cited by 12 · see citing works
Loss of lysosomal acid lipase contributes to Alzheimer's disease pathology and cognitive decline
Barnett, A. M., McNair, E. M., Dawkins, L., Zou, J., Nikolova, V. D., Moy, S. S., Sutherland, G. T., Stevens, J., Colie, M., Katemboh, K., et al. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.70486 · Cited by 12 · see citing works
Iwahata, D., Tsuda, M., Aigaki, T., & Miyano, H. (2011) · Journal of Analytical Atomic Spectrometry · doi:10.1039/c1ja10212e · Cited by 9 · see citing works
Davies, E. S., Morphew, R. M., Cutress, D. J., Morton, A. J., & McBride, S. D. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04572-z · Cited by 9 · see citing works
Dépistage précoce de la démence : annonce du diagnostic et dimensions éthiques
Jm, L., & Ouango, J. G. (2001) · Gérontologie et société · doi:10.3917/gs.097.0095 · Cited by 8 · see citing works
Localization of HtrA2/Omi immunoreactivity in brains affected by Alzheimer’s disease
Kawamoto, Y., Ito, H., Kobayashi, Y., Suzuki, Y., & Takahashi, R. (2010) · Neuroreport · doi:10.1097/wnr.0b013e328340a731 · Cited by 8 · see citing works
Nishizaki, T. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1408-y · Cited by 7 · see citing works
Iwahata, D., Nakamura, K., Yamada, R., Miyano, H., & Yamada, N. (2013) · Journal of Analytical Sciences Methods and Instrumentation · doi:10.4236/jasmi.2013.32010 · Cited by 5 · see citing works
Regional and Laminar Patterns of Selective Neuronal Vulnerability in Alzheimer's Disease
Hof, P. R. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50011-1 · Cited by 2 · see citing works
Delshad, N., Ghayour‐Mobarhan, M., Mirzaei, H., Razavi-Azarkhiavi, K., Moohebati, M., Hassany, M., Kasaian, J., Etemadzadeh, M. R., Alavi, M.-S., & Behravan, J. (2016) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.23942 · Cited by 2 · see citing works
Early Intraneuronal β-Amyloid Pathology: Do Transgenic Mice Represent Valid Model Systems?
Wirths, O., & Bayer, T. A. (2008) · The Open Aging Journal · doi:10.2174/1874369200802010007 · Cited by 2 · see citing works
Liu, M., Zhu, L., Li, F., Shi, X., Shen, Y.-F., & Liu, M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.06.579113 · Cited by 2 · see citing works
Pierzynowska, K., Gaffke, L., Cyske, Z., Jerzemowska, G., Węgrzyn, G., & Podlacha, M. (2026) · Nutritional Neuroscience · doi:10.1080/1028415x.2026.2634117 · Cited by 1 · see citing works
ENRIQUECIMIENTO AMBIENTAL EN RATONES 3xTgAD
Alzheimer, M. D. (2011)
Clinicopathological Stratification of Idiopathic Autism and Autism with 15q11.2–q13 Duplications
Węgiel, J., Schanen, N. C., Cook, E. H., Brown, W. T., Kuchna, I., Nowicki, K., Wegiel, J., Imaki, H., Ma, S. Y., London, E., et al. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391924-3.00025-9
Castelot, R. (2024) · theses.fr (ABES) · doi:10.70675/c2a7ce1ez8caaz4593zbb3azae8add8055b5
- Authors
- Mochizuki, A., Tamaoka, A., Shimohata, A., Komatsuzaki, Y., & Shoji, S.
- Affiliations
- University of Tsukuba (JP)
- ORCID
- Tamaoka, Akira
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2000-01
- Volume
- 355
- Issue
- 9197
- Pages
- 42-43
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W1967168807
- Cited by
- 85
- References
- 5
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 1 · 2020: 1 · 2018: 4 · 2016: 1 · 2014: 3 · 2013: 2 · 2012: 4
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid-beta 42, amyloid plaques, non-pyramidal neurons, intracellular amyloid-beta, Aβ40
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Brain, Female, Humans, Male, Middle Aged, Neurons, Case-Control Studies, Amyloid beta-Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review